
Ask a doctor about a prescription for BRAQUIX 25/50 micrograms/inhalation, pressurized inhalation suspension
Package Leaflet: Information for the Patient
Braquix 25 micrograms/50 micrograms/inhalation, suspension for inhalation in a pressurized container
Read the entire package leaflet carefully before starting to use this medication, as it contains important information for you.
Contents of the Package Leaflet
Braquix contains two active substances: salmeterol and fluticasone propionate:
Your doctor has prescribed this medication to help prevent respiratory problems such as asthma.
You should use Braquix every day, as your doctor has recommended. This will ensure that the medication works correctly to control your asthma.
Salmeterol/Fluticasone helps prevent shortness of breath and wheezing. However, salmeterol/fluticasone should not be used to relieve a sudden attack of shortness of breath or wheezing. If this happens, you should use your fast-acting "rescue" medication, such as salbutamol. You should always carry your fast-acting rescue medication with you.
Do not take Braquix:
Consult your doctor or pharmacist before taking salmeterol/fluticasone if you have:
Consult your doctor if you experience blurred vision or other visual disturbances.
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medications, including medications for asthma or any medication obtained without a prescription. This is because salmeterol/fluticasone may not be suitable to be taken with some other medications.
Tell your doctor if you are taking the following medications before starting to use Salmeterol/Fluticasone:
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Salmeterol/Fluticasone is unlikely to affect your ability to drive or use machines.
Follow the instructions for administration of this medication exactly as indicated by your doctor or pharmacist. If you are in doubt, consult your doctor or pharmacist again.
However, it is not possible to know when the inhaler is empty and when the 120 applications have been released. It is possible that a small amount of liquid may still be left in the container.
Please make sure to replace your inhaler after releasing 120 applications so that you can be sure you are receiving the correct amount of medication in each application.
Your symptoms may be well-controlled using salmeterol/fluticasone twice a day. If this is the case, your doctor may decide to reduce your dose to once a day. The dose may change to:
It is very important that you follow your doctor's instructions on how many applications and how often you should administer them.
If you are using this medication to treat asthma, your doctor will want to monitor your symptoms regularly.
If your asthma worsens or you have more difficulty breathing, see your doctor immediately.You may notice more wheezing or shortness of breath, chest tightness, or that you need to use your fast-acting rescue medication more often. If any of these things happen, you should continue using Braquix, but do not increase the number of applications. Your respiratory disease may worsen, and you may become seriously ill. See your doctor, as you may need additional treatment.
Never separate the metal cartridge from the inhaler.
Only if the inhaler becomes very cold (below 0°C), remove the metal cartridge from the plastic casing and warm it in your hands for a few minutes before using it. Never use anything else to warm it. Once warmed and before using it, press the cartridge firmly to release two applications into the air.
It is essential to start breathing in as slowly as possible just before using your inhaler.





Take your time in steps 5, 6, 7, and 8. It is essential that you start breathing in as slowly as possible just before using your inhaler. The first few times you use the inhaler, you should use it in front of a mirror. If you see "mist" coming out of the top of the inhaler or the sides of your mouth, you should start again from step 4.
As with all inhalers, caregivers should ensure that children using salmeterol/fluticasone use the correct inhalation technique described above.
If you or your child find it difficult to use the inhaler, your doctor, nurse, or pharmacist may recommend using a spacer device, AeroChamber Plus, with your inhaler. Your doctor, nurse, pharmacist, or other healthcare professional should show you how to use the spacer device with your inhaler and how to maintain your spacer device, and answer any questions you may have. If you are using the spacer device with your inhaler, it is essential that you do not stop using it without consulting your doctor or nurse first. It is not recommended to use other spacer devices with Braquix, and you should not switch from the AeroChamber Plus to another device.It is also essential that you do not change or stop using the spacer without consulting your doctor; they will know how to modify your therapy. Always consult your doctor before making any changes to your asthma treatment.
Some children or people with little hand strength may find it easier to hold the inhaler with both hands. Place your two index fingers on the top of the inhaler and both thumbs on the base, below the mouthpiece.
To prevent blockage of your inhaler, it is essential to clean it at least once a week.
To clean your inhaler:
It is essential to use the inhaler exactly as indicated. If you accidentally take a higher dose than recommended, consult your doctor or pharmacist. You may notice that your heart beats faster than normal, and you may feel tremors. You may also have a headache, dizziness, weakness, and joint pain.
If you have used high doses for extended periods, you should ask your doctor or pharmacist for advice. This is because high concentrations of salmeterol/fluticasone may reduce the amount of steroid hormones produced by the adrenal gland.
In case of overdose or accidental ingestion, consult your doctor or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
Do not take a double dose to make up for forgotten doses. Take the next dose at the usual time.
It is very important that you take your salmeterol/fluticasone every day as indicated. Continue taking it until your doctor tells you to stop. Do not interrupt or suddenly reduce your treatment with salmeterol/fluticasone. This could make your breathing worse.
Additionally, if you suddenly stop taking this medication or reduce your dose of salmeterol/fluticasone, you may (very rarely) experience problems with your adrenal gland (adrenal insufficiency), which can sometimes cause side effects.
These side effects may include:
When your body is under stress, such as fever, trauma (such as a car accident), infection, or surgery, adrenal insufficiency may worsen, and you may experience any of the above side effects.
If you experience any side effects, consult your doctor or pharmacist. To prevent these symptoms, your doctor may prescribe an additional dose of corticosteroids in tablets (such as prednisolone).
If you have any further questions about the use of this medication, ask your doctor, pharmacist, or nurse.
Like all medications, this medication may cause side effects, although not everyone may experience them. To reduce the possibility of side effects, your doctor will prescribe the lowest dose of salmeterol/fluticasone necessary to control your asthma.
The following are other side effects:
The following side effects have been reported in patients with Chronic Obstructive Pulmonary Disease (COPD):
The effects include:
Your doctor will regularly monitor any of these adverse effects and ensure that you are taking the lowest dose of salmeterol/fluticasone to control your asthma.
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Do not use Braquix after the expiration date shown on the label and on the carton after CAD. The expiration date is the last day of the month indicated.
Do not store at a temperature above 25°C.
The cartridge contains a pressurized liquid. Do not expose it to temperatures above 50°C, protect it from direct sunlight. Do not puncture, break, or burn the cartridge even if it is empty.
Do not use this medication if you observe visible signs of deterioration.
As with most medications administered by inhalation in pressurized cartridges, the therapeutic effect may decrease if the cartridge is cooled.
Medications should not be thrown away through wastewater or household waste. Deposit the packaging and medications you no longer need at the Sigre Point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This way, you will help protect the environment.
The active ingredients are salmeterol and fluticasone propionate. Each pressurized dose contains 25 micrograms of salmeterol (as salmeterol xinafoate) and 50 micrograms of fluticasone propionate.
The other ingredient is the propellant: norflurane (HFA 134a).
MABO-FARMA, S.A.
Calle Vía de los Poblados 3, Edificio 6,
28033 Madrid,
Spain.
Manufacturer
GENETIC, S.P.A.
Contrada Canfora
Fisciano, Salerno
84084 Italy
Country | Medication name |
Portugal: | Flusonide |
Spain: | Braquix 25 micrograms/50 micrograms/inhalation, inhalation suspension in pressurized container. |
Date of the last revision of this leaflet:09/2021
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for BRAQUIX 25/50 micrograms/inhalation, pressurized inhalation suspension – subject to medical assessment and local rules.